Clinical Trial Update: Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a fixed-dose Naratriptan/Naproxen combination for acute treatment of migraine was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Migraine

Drugs mentioned

• Naproxen (Naproxen)
• Naratriptan (Naratriptan)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Migraine, Headache | Phase 3 | Status: WITHDRAWN